Article info
PDFOriginal article
Comparison of Pathvysion and Poseidon HER2 FISH assays in measuring HER2 amplification in breast cancer: a validation study
- Correspondence to Zoltan Szollosi, Department of Pathology, Josa Andras County Hospital, Szent Istvan u 68, H-4400 Nyiregyhaza, Hungary; szollosi{at}dote.hu
Citation
Comparison of Pathvysion and Poseidon HER2 FISH assays in measuring HER2 amplification in breast cancer: a validation study
Publication history
- Accepted November 23, 2009
- First published December 3, 2009.
Online issue publication
August 10, 2020
Article Versions
- Previous version (10 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited For permission to use, (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.